All Stories

  1. Critical Limb Ischemia benefits from angiogenesis produced by growth hormone
  2. GPE Promotes the Proliferation and Migration of Mouse Embryonic Neural Stem Cells and Their Progeny In Vitro
  3. Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases
  4. Growth Hormone (GH) and Rehabilitation Promoted Distal Innervation in a Child Affected by Caudal Regression Syndrome
  5. Clonidine Plus GHRH Administration for Diagnosing Growth Hormone Deficiency in Children
  6. Growth Hormone (GH) and Rehabilitation Promoted Distal Innervation in a Child Affected from a Syndrome of Caudal Regression
  7. Learning and Memory Recoveries in a Young Girl Treated with Growth Hormone and Neurorehabilitation
  8. Growth Hormone effects in the human body
  9. Brain Recovery after a Plane Crash: Treatment with Growth Hormone (GH) and Neurorehabilitation: A Case Report
  10. Growth hormone pathways signaling for cell proliferation and survival in hippocampal neural precursors from postnatal mice
  11. Role of growth hormone (GH) in the treatment on neural diseases: From neuroprotection to neural repair
  12. Growth hormone (GH) and brain trauma
  13. Myostatin expression is regulated by underfeeding and neonatal programming in rats
  14. Growth Hormone and Kynesitherapy for Brain Injury Recovery
  15. Growth hormone treatment enhances the functional recovery of sciatic nerves after transection and repair
  16. Growth Hormone administration increases cognition in cerebral palsy
  17. Growth hormone (GH) treatment may cooperate with locally-produced GH in increasing the proliferative response of hippocampal progenitors to kainate-induced injury
  18. Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury
  19. Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy
  20. Hormona de crecimiento: acciones y aplicaciones preventivas y terapéuticas
  21. Growth hormone deficiency and cerebral palsy
  22. Recovery from neurological sequelae secondary to oncological brain surgery in an adult growth hormone-deficient patient after growth hormone treatment
  23. Clonidine Potentiates the Growth Hormone Response to a Growth Hormone Releasing Hormone Challenge in Hypothalamic Growth Hormone Releasing Hormone Deficient Rats
  24. Clonidine Potentiates the Growth Hormone (GH) Response to GH-Releasing Hormone in Norepinephrine Synthesis-Inhibited Rats: Evidence for an Alpha-2-Adrenergic Control of Hypothalamic Release of Somatostatin
  25. Role of Central Dopaminergic Pathways in the Neural Control of Growth Hormone Secretion in Normal Men: Studies with Metoclopramide
  26. Depending on the Time of Administration, Dexamethasone Potentiates or Blocks Growth Hormone-Releasing Hormone-Induced Growth Hormone Release in Man
  27. Muscle Myostatin Expression in Children With Muscle Diseases
  28. Reply
  29. Myostatin Expression in Muscular Dystrophies and Mitochondrial Encephalomyopathies
  30. Differential Response to Exogenous and Endogenous Myostatin in Myoblasts Suggests that Myostatin Acts as an Autocrine Factorin Vivo
  31. Activation of Human Somatostatin Receptor 2 Promotes Apoptosis Through a Mechanism that is Independent from Induction of p53
  32. Myostatin Regulates Cell Survival during C2C12 Myogenesis
  33. Proteolytic processing of human growth hormone (GH) by rat tissues in vitro: Influence of sex and age
  34. N-Glycosylated Variants of Growth Hormone in Human Pituitary Extracts
  35. Role of Growth Hormone Receptor in HL-60 Cell Survival
  36. Activation of Growth Hormone Receptor Delivers an Antiapoptotic Signal: Evidence for a Role of Akt in This Pathway1
  37. Correlation of Pit-1 Gene Expression and Pit-1 Content with Proliferation and Differentiation in Human Myeloid Leukemic Cells
  38. Pattern of Presentation of the Human Growth Hormone Variant (hGH-V) Gene in the Normal Population
  39. Expression of the Human Growth Hormone Normal Gene (hGH-N) in Proliferating and Differentiated HL-60 Cells
  40. Regulation of hypothalamic somatostatin by glucocorticoids
  41. A 12-kilodalton N-glycosylated growth hormone-related peptide is present in human pituitary extracts
  42. A 12-kilodalton N-glycosylated growth hormone-related peptide is present in human pituitary extracts.
  43. Glucocorticoids may inhibit growth hormone release by enhancing beta- adrenergic responsiveness in hypothalamic somatostatin neurons
  44. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
  45. Studies on α2-adrenergic modulation of hypothalamic somatostatin secretion in rats
  46. Neuroendocrine control of growth hormone secretion in humans
  47. Evidence thatα2-Adrenergic Pathways Play a Major Role in Growth Hormone (GH) Neuroregulation:α2-Adrenergic Agonism Counteracts the Inhibitory Effect of Muscarinic Cholinergic Receptor Blockade on the GH Response to GH-Releasing Hormone, whileα2-Adrener...
  48. Clonidine pretreatment modifies the growth hormone secretory pattern induced by shortterm continuous GRF infusion in normal man
  49. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans
  50. α2-Adrenergic Agonism Enhances the Growth Hormone (GH) Response to GH-Releasing Hormone through an Inhibition of Hypothalamic Somatostatin Release in Normal Men*
  51. Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs
  52. Study of the Source(s) of Hyperandrogenism in Women with Idiopathic Hirsutism
  53. Effects of bromocriptine on pituitary and adrenal cortex in pre-adrenarchal rabbits
  54. REASONS FOR THE VARIABILITY IN GROWTH HORMONE (GH) RESPONSES TO GHRH CHALLENGE: THE ENDOGENOUS HYPOTHALAMIC-SOMATOTROPH RHYTHM (HSR)
  55. Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade
  56. Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary
  57. Adrenal Androgen Secretion and Dopaminergic Activity in Anorexia Nervosa
  58. Dopamine acts on acetylation of proopiomelanocortin-derived products in dog pituitary
  59. GROWTH HORMONE AND PROLACTIN SECRETION AFTER GROWTH HORMONE-RELEASING HORMONE ADMINISTRATION, IN ANOREXIA NERVOSA PATIENTS, NORMAL CONTROLS AND TAMOXIFEN-PRETREATED VOLUNTEERS
  60. Morphological and functional stimulation of adrenal reticularis zone by dopaminergic blockade in dogs
  61. Steroids and neuroendocrine function in anorexia nervosa
  62. Adrenal cortex and type II polycystic ovary syndrome
  63. ATROPINE SELECTIVELY BLOCKS GHRH-INDUCED GH SECRETION WITHOUT ALTERING LH, FSH, TSH, PRL AND ACTH/CORTISOL SECRETION ELICITED BY THEIR SPECIFIC HYPOTHALAMIC RELEASING FACTORS
  64. GLUCOCORTICOID DEFICIENCY WITH ACHALASIA OF THE CARDIA AND LACK OF LACRIMATION
  65. Metabolic and Hormonal Parameters after Insulin- Induced Hypoglycemia in Man, Comparison between Biosynthetic Human Insulin and Purified Pork Insulin